In addition, sodium valproate could increase the expression of adipokines in the brain and pituitary (cephalokines), which regulates resistin and angiopoietin-like protein 4 (ANGPTL4) that might have a role in obesity and insulin resistance (26). Here, RETN is linked to obesity due to melanocortin 4 receptor deficiency.